The present invention relates to a device for delivering acetylsalicylic acid or a salt thereof for the administration thereof through oral inhalation route for the preventive or curative treatment of thrombohemolytic events, in particular for myocardial infarction.

A breathing treatment delivery device is disclosed for providing atomized medicine or oxygen to a patient. The breathing treatment delivery device can include a supply device configured to dispense atomized medicine or oxygen through a dispensing end of the supply device. A cap can have a device side and a delivery side, the device side including an opening receiving and in fluid communication with the dispensing end of the supply device. A treat holder can be positioned on the delivery side of the cap. At least one aperture can be defined in the delivery side of the cap adjacent the treat holder, a pneumatic passage formed through the cap between the opening in the device side of the cap and the aperture. A patient can enjoy a piece of candy or other treat retained by the treat holder during treatment while breathing in the desired medicine or oxygen.

An aerosol generator with an active liquid container and a nebulization chamber associated therewith, which is connected to an inlet channel for the supply of carrier gas and to an outlet channel for the discharge of carrier gas mixed with aerosol obtained from the active liquid, is intended to enable a particularly good adjustability of the droplet size of the aerosols contained in the discharged carrier gas and thus a use particularly in the context of a transnasal inhalation therapy. For this purpose, the nebulization chamber has a substantially rotationally symmetrical boundary wall, the inlet channel being positioned and oriented in the region of its point of entry into the nebulization chamber in such a way that its longitudinal axis is offset relative to the axis of symmetry of the nebulization chamber in the region of the point of entry and does not intersect the axis of symmetry.

The invention relates to a small-volume nebulizer that is pre-filled with at least one unit-dose of medicine and hermetically sealed until use. The nebulizer may be sealed at the top with a removable cap that may be detached at the time of use and replaced with a patient connector. Likewise, the nebulizer may be sealed at the bottom with a bottom cap that is replaced with a gas source at the beginning of a therapeutic aerosol treatment.

A humidification system including a conduit for carrying breathing gases, a pump to pressurize a liquid for injection into breathing gases, a liquid-injection nozzle protruding at least partially into the conduit and configured to inject liquid, pressurized by the pump, into the conduit; and a heated surface protruding into the conduit and positioned to vaporize the liquid injected by the nozzle, wherein the heated surface crosses a flow path of the breathing gases flowing through the conduit.

A nebulizer and a nozzle thereof are provided. The nozzle has a containing seat and a cover. The containing seat has an air conduit. The air conduit has an input terminal and an output terminal. The cover has a guiding channel and an impediment. An input opening is formed in the nozzle for introducing air. A first opening of the guiding channel is disposed near the output terminal and the input opening is disposed far of the output terminal. The impediment is disposed in front of the output terminal and has a plane. Air emitted from the output terminal lashes the plane and then flows to a second opening of the guiding channel, and the air of the input opening is guided to the first opening for decreasing a whole resistance of the nozzle, and thereby increasing nebulization efficiency.

A supplemental oxygen delivery system is described in which Aerosol is delivered into a housing 10, 20, which sits in the circuit from the supplemental oxygen supply and optional humidifier. The supplemental oxygen passes through this chamber 10, 20 in which the aerosol is located, and collects the aerosol transporting it to a patient via a nasal cannula 3 or a face mask 4. An aerosol generator 9 is mounted to the housing 10, 20 and delivers aerosol into an oxygen stream 13 flowing between an inlet 14 and an outlet 15 of the housing 10. The housing 10 also has a removable plug 16 in the base 17 thereof for draining any liquid that accumulates in the housing 10. There is no disruption of oxygen delivery to patients using nasal cannulas who currently have to use a separate face-mask when receiving nebulized medication.

The present invention relates to a kit comprising: a) an ampoule; b) a material comprising a hemp plant or parts thereof; and c) a color indicator capable of reacting by contacting the hemp plant and/or at least a part thereof to change the color of the color indicator, wherein the material and the color indicator are disposed in the ampoule; and a method for qualitatively and/or quantitatively detecting one or more substance(s) contained in the hemp plant using the kit.

The present disclosure generally relates to the field of nebulizers for aerosol generation and methods of using same for treating diseases and disorders.

The invention relates to a nebulizer (1) comprising an aerosol generator (6), a nebulizing chamber (5) and an outlet (16), the aerosol generator (6) being designed to release an aerosol into the nebulizing chamber (5) and the outlet (16) being designed to allow the removal of the aerosol from the nebulizing chamber (5). To achieve a high output rate, a wetting surface (2) is provided in the nebulizing chamber (5).